Search research articles
Contact Us
Filters
Showing results (301-310 of 473) with videos related to
Page
of 48
Sort By:
Pathogens (Basel, Switzerland)
|
January 8, 2025
Antimicrobial Susceptibility Trends in <i>E. coli</i> Causing Pediatric Urinary Tract Infections in the United States
Simren Mahajan, Neena Kanwar, Gina M Morgan, et al.
Jac-Antimicrobial Resistance
|
December 17, 2021
<i>In vitro</i> activity of a novel aminomethylcycline antibacterial (KBP-7072), a third-generation tetracycline, against clinical isolates with molecularly characterized tetracycline resistance mechanisms
Michael A Pfaller, Li Li, Qingmei Liu, et al.
Open Forum Infectious Diseases
|
March 22, 2019
Antimicrobial Resistance Surveillance and New Drug Development
Helio S Sader, Paul R Rhomberg, Andrew S Fuhrmeister, et al.
Diagnostic Microbiology and Infectious Disease
|
January 31, 2015
In vitro activity of linezolid as assessed through the 2013 LEADER surveillance program
Robert K Flamm, Rodrigo E Mendes, Patricia A Hogan, et al.
Memorias Do Instituto Oswaldo Cruz
|
September 14, 2010
Evaluation of local immune response to Fasciola hepatica experimental infection in the liver and hepatic lymph nodes of goats immunized with Sm14 vaccine antigen
Ricardo E Mendes, Rafael Zafra, Rafael A Pérez-Ecija, et al.
Antimicrobial Agents and Chemotherapy
|
February 3, 2016
Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014)
Robert K Flamm, Rodrigo E Mendes, Patricia A Hogan, et al.
Journal of Clinical Microbiology
|
November 27, 2009
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid
Rodrigo E Mendes, Helio S Sader, Lalitagauri M Deshpande, et al.
Journal of Chemotherapy (Florence, Italy)
|
November 24, 2012
ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countries
Robert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
March 18, 2020
Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018
Robert K Flamm, Leonard R Duncan, Kamal A Hamed, et al.
Diagnostic Microbiology and Infectious Disease
|
September 24, 2013
Update of contemporary antimicrobial resistance rates across China: reference testing results for 12 medical centers (2011)
Ronald N Jones, Mariana Castanheira, Bijie Hu, et al.
Page
of 48
Search research articles
Search
Showing results (301-310 of 473) with videos related to
Sort By:
Page
of 48
Pathogens (Basel, Switzerland)
|
January 8, 2025
Antimicrobial Susceptibility Trends in <i>E. coli</i> Causing Pediatric Urinary Tract Infections in the United States
Simren Mahajan, Neena Kanwar, Gina M Morgan, et al.
Jac-Antimicrobial Resistance
|
December 17, 2021
<i>In vitro</i> activity of a novel aminomethylcycline antibacterial (KBP-7072), a third-generation tetracycline, against clinical isolates with molecularly characterized tetracycline resistance mechanisms
Michael A Pfaller, Li Li, Qingmei Liu, et al.
Open Forum Infectious Diseases
|
March 22, 2019
Antimicrobial Resistance Surveillance and New Drug Development
Helio S Sader, Paul R Rhomberg, Andrew S Fuhrmeister, et al.
Diagnostic Microbiology and Infectious Disease
|
January 31, 2015
In vitro activity of linezolid as assessed through the 2013 LEADER surveillance program
Robert K Flamm, Rodrigo E Mendes, Patricia A Hogan, et al.
Memorias Do Instituto Oswaldo Cruz
|
September 14, 2010
Evaluation of local immune response to Fasciola hepatica experimental infection in the liver and hepatic lymph nodes of goats immunized with Sm14 vaccine antigen
Ricardo E Mendes, Rafael Zafra, Rafael A Pérez-Ecija, et al.
Antimicrobial Agents and Chemotherapy
|
February 3, 2016
Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014)
Robert K Flamm, Rodrigo E Mendes, Patricia A Hogan, et al.
Journal of Clinical Microbiology
|
November 27, 2009
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid
Rodrigo E Mendes, Helio S Sader, Lalitagauri M Deshpande, et al.
Journal of Chemotherapy (Florence, Italy)
|
November 24, 2012
ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countries
Robert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
March 18, 2020
Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018
Robert K Flamm, Leonard R Duncan, Kamal A Hamed, et al.
Diagnostic Microbiology and Infectious Disease
|
September 24, 2013
Update of contemporary antimicrobial resistance rates across China: reference testing results for 12 medical centers (2011)
Ronald N Jones, Mariana Castanheira, Bijie Hu, et al.
Page
of 48